Global Fund To Fight Aids Tuberculosis And Malaria: $6.3B Revenue, $3.9B Program Expenses
Switzerland, Unknown · EIN 980380092 · Filing year 2023
Global Fund To Fight Aids Tuberculosis And Malaria reported $6.3B in total revenue, $5.0B in total expenses, and $9.3B in total assets on its 2023 IRS Form 990. 78.0% of expenses ($3.9B) went directly to programs. Top officer compensation is not reported on this 990 filing. Overall efficiency grade: B (75/100).
Source: ProPublica Nonprofit Explorer — IRS Form 990 filings, filing year 2023.
Key Facts (2023 Form 990)
- Total Revenue
- $6.3B
- Total Expenses
- $5.0B
- Program Expenses
- $3.9B
- Program Expense Ratio
- 78.0%
- Total Assets
- $9.3B
- Reserve Months
- 22.1 months
- EIN
- 980380092
- Latest 990 Year
- 2023
- Top Officer Compensation
- Not reported
The efficiency rubric puts Global Fund To Fight Aids Tuberculosis And Malaria at a B grade: a composite of 75/100 that lands above the national midpoint. The grade reflects solid program-spending discipline alongside reasonable executive compensation and financial reserves.
On revenue, Global Fund To Fight Aids Tuberculosis And Malaria is among the largest U.S. nonprofits: $6.3B in 2023 reported revenue. Organizations at this scale typically operate hospitals, university systems, or national federations — the financial pattern looks more like a corporation than the small-charity stereotype. Program-spending efficiency is strong: 80% of total expenses flow to program activities, above the 75% benchmark most third-party charity raters use.
Five-year revenue trajectory is strongly positive: Global Fund To Fight Aids Tuberculosis And Malaria has grown materially in real terms, which usually signals successful fundraising and program expansion. CEO compensation is reported as zero in the filing — typical for nonprofits where the chief executive is paid through a related entity (parent system, university, or foundation) rather than the filing organization itself, or for small organizations whose chief is a volunteer or board member. Global Fund To Fight Aids Tuberculosis And Malaria is in the Medical Research category — public-affairs, civic, and research-policy organizations. The sector includes think tanks, advocacy organizations, and policy-research nonprofits.
How Global Fund To Fight Aids Tuberculosis And Malaria Compares
Global Fund To Fight Aids Tuberculosis And Malaria directs 78.0% of spending to programs, meeting the 65% minimum recommended by charity watchdogs. Its efficiency score of 75/100 is 6 points below the Medical Research category average. The organization holds 22.1 months of operating reserves, indicating strong financial stability.
Where Your Donation Goes
Based on IRS tax-exempt organization data, for every dollar donated to Global Fund To Fight Aids Tuberculosis And Malaria, approximately 78.0 cents goes directly to program activities. The remaining funds cover administrative costs, fundraising, and management expenses.
Revenue History
Global Fund To Fight Aids Tuberculosis And Malaria has an Efficiency Score of B (75/100). Approximately 78.0% of expenses go directly to program activities, with the remainder covering administration and fundraising.
Global Fund To Fight Aids Tuberculosis And Malaria, Donor FAQ
Global Fund To Fight Aids Tuberculosis And Malaria has an Efficiency Score of B (75/100). Approximately 78.0% of expenses go directly to program activities, with the remainder covering administration and fundraising.
CEO/officer compensation for Global Fund To Fight Aids Tuberculosis And Malaria is not reported in the most recent IRS 990 filing on file.
Global Fund To Fight Aids Tuberculosis And Malaria reported $6.3B in annual revenue and $5.0B in total expenses for filing year 2023. The organization holds $9.3B in total assets.
For every dollar donated to Global Fund To Fight Aids Tuberculosis And Malaria, approximately 78.0 cents goes to program activities. The organization has 22.1 months of operating reserves, providing financial stability to sustain its mission.
Global Fund To Fight Aids Tuberculosis And Malaria is a registered 501(c) organization with EIN 980380092, based in Switzerland, Unknown. Financial data is sourced from publicly available IRS 990 filings via ProPublica Nonprofit Explorer.
Similar Medical Research Nonprofits
Financial data is sourced from IRS 990 filings via ProPublica Nonprofit Explorer. Efficiency Scores combine program spending ratio (50%), revenue growth (20%), reserve months (20%), and CEO compensation ratio (10%). Filing data may lag 6-18 months from the tax year.